The Guilford Foundation (TGF) has announced the start of its year-long 50th anniversary celebration, which will commemorate ...
Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...
About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that ...
Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...
About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that ...
The Smad2/3 pathway plays a key role in mediating TGF-β1 inhibition of branching morphogenesis and induction of connective tissue growth factor (CTGF) expression in embryonic lungs. Because a ...
With three growth factor technologies working in harmony—EGF, IGF, and TGF—it helps promote collagen, elastin, and hydration, ...
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Tribeca Global Natural Resources Limited (TGF). However, you won't necessarily see their names ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback